文献速递呼吸道感染呼吸危重症与机械通气

SARS-CoV-2与其他呼吸道病毒的临床表型与结局比较

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.
PubMed 文献 · Thorax · 2021-07-05

该回顾性队列研究纳入2011至2020年住院成人与儿童呼吸道病毒检测阳性者,比较SARS-CoV-2与流感、RSV等十种呼吸道病毒的临床表型与结局。成人中SARS-CoV-2阳性与较年轻、男性、超重/肥胖、糖尿病、高血压等相关,且30天死亡率显著高于流感(aHR 4.43)、RSV(aHR 3.81)及其他呼吸道病毒(aHR 3.46),90天死亡率、ICU入住率、ICU死亡率及肺栓塞亦更高。

要点

  • 成人SARS-CoV-2感染30天死亡风险显著高于流感、RSV及其他呼吸道病毒。
  • SARS-CoV-2阳性成人更常见年轻、男性、超重/肥胖、糖尿病和高血压。
  • 尽管有特征差异,但临床特征重叠明显,难以单独据此鉴别。

核心结论

  • SARS-CoV-2感染与其他呼吸道病毒相比结局更严重。
  • 尽管SARS-CoV-2与特定患者和临床特征相关,但特征重叠明显,无法据此区分。

研究设计与样本

  • 回顾性队列研究,纳入2011至2020年入院时呼吸道样本检测阳性的住院成人和儿童(≤15岁)。
  • 成人共6321例(其中SARS-CoV-2 1721例),儿童共6379例(其中SARS-CoV-2 101例)。

主要发现

  • 成人中SARS-CoV-2阳性独立关联于较年轻、男性、超重/肥胖、糖尿病、高血压、呼吸急促及较好的血流动力学指标、白细胞计数、血小板计数和肌酐值。
  • 成人SARS-CoV-2阳性30天死亡率高于流感(aHR 4.43,95%CI 3.51-5.59)、RSV(aHR 3.81,95%CI 2.72-5.34)和其他呼吸道病毒(aHR 3.46,95%CI 2.61-4.60)。
  • 成人SARS-CoV-2阳性90天死亡率、ICU入住率、ICU死亡率和肺栓塞发生率更高。
  • 儿童中SARS-CoV-2阳性者年龄较大,慢性心脏病和呼吸系统疾病患病率低于其他病毒感染者。

临床怎么用

  • 临床中应认识到SARS-CoV-2感染较其他呼吸道病毒具有更高的死亡和重症风险。
  • 不能仅凭入院时的临床特征区分SARS-CoV-2与其他呼吸道病毒感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. METHODS: We performed a retrospective cohort study of hospitalised adults and children (≤15 years) who tested positive for SARS-CoV-2, influenza virus A/B, RSV, rhinovirus, enterovirus, parainfluenza viruses, metapneumovirus, seasonal coronaviruses, adenovirus or bocavirus in a respiratory sample at admission between 2011 and 2020. RESULTS: A total of 6321 adult (1721 SARS-CoV-2) and 6379 paediatric (101 SARS-CoV-2) healthcare episodes were included in the study. In adults, SARS-CoV-2 positivity was independently associated with younger age, male sex, overweight/obesity, diabetes and hypertension, tachypnoea as well as better haemodynamic measurements, white cell count, platelet count and creatinine values. Furthermore, SARS-CoV-2 was associated with higher 30-day mortality as compared with influenza (adjusted HR (aHR) 4.43, 95% CI 3.51 to 5.59), RSV (aHR 3.81, 95% CI 2.72 to 5.34) and other respiratory viruses (aHR 3.46, 95% CI 2.61 to 4.60), as well as higher 90-day mortality, ICU admission, ICU mortality and pulmonary embolism in adults. In children, patients with SARS-CoV-2 were older and had lower prevalence of chronic cardiac and respiratory diseases compared with other viruses. CONCLUSIONS: SARS-CoV-2 is associated with more severe outcomes compared with other respiratory viruses, and although associated with specific patient and clinical characteristics at admission, a substantial overlap precludes discrimination based on these characteristics.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Hedberg P, Karlsson Valik J, van der Werff S, et al. Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data. Thorax. 2021. PMID: 34226206. doi:10.1136/thoraxjnl-2021-216949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。